Comparison of low dose midazolam and etomidate for the Prevention of myoclonic Movements following etomidate Injection.
Phase 3
- Conditions
- Myoclonic Movements.
- Registration Number
- IRCT20160307026950N6
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
All Patients candidate Electroconvulsive Therapy
ASA I,ASAII
Age 6 - 15 years
Exclusion Criteria
Severe cardiovascular disease
kidney disease
Liver disease
Chronic respiratory disease
drugs Allergy
discontinue of cooperation
intubation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method